Table 2.
Indicator | Groups | AUC (95%CI) | Cutoff value | Sensitivity | Specificity |
TFF3 | CA vs CRC | 0.834 (0.796, 0.873) | 29.89 | 75.23% | 78.28% |
CA vs early stage CRC | 0.751 (0.691, 0.812) | 29.89 | 58.54% | 78.28% | |
CA vs advanced CRC | 0.886 (0.849, 0.923) | 34.07 | 75.00% | 89.39% | |
CEA | CA vs CRC | 0.683 (0.630, 0.737) | 4.96 | 57.01% | 85.86% |
CA vs early CRC | 0.648 (0.563, 0.734) | 4.53 | 56.10% | 81.31% | |
CA vs advanced stage CRC | 0.705 (0.641, 0.770) | 4.96 | 60.61% | 85.86% | |
TFF3+CEA | CA vs CRC | 0.883 (0.851, 0.915) | 0.57 | 73.83% | 88.38% |
CA vs early stage CRC | 0.823 (0.768, 0.878) | 0.41 | 76.83% | 77.27% | |
CA vs advanced stage CRC | 0.919 (0.888, 0.951) | 0.57 | 81.82% | 88.38% |
TFF3: Trefoil factors family; CA: Colorectal adenoma; CRC: Colorectal cancer; AUC: Area under curve.